Trial Profile
Comparison of Global and Voxel-Based Diagnostic Classification Using [18F]Florbetapir ROC Estimates
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Oct 2015
Price :
$35
*
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 20 Oct 2015 New trial record